FDA Approved: SPIRONOLACTONE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA has approved a supplemental application for spironolactone from Jubilant Cadista Pharmaceuticals Inc. under the ANDA framework.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis with Ascites
• Edema
• Heart Failure
• Hyperaldosteronism
• Hypertension
• Nephrotic Syndrome

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)